The 2025 FSP Trends Report highlights the increasing utilization of Functional Service Provider (FSP) solutions by biopharma and biotech companies to navigate challenges in drug discovery, such as rising costs, patient recruitment, and complexity. These partnerships enable companies to meet timelines and stay within budget. The report explores the latest growth projections for FSP partnerships, innovative strategies, and how to leverage the FSP model for on-time and on-budget delivery.

Join for free to read